Drug Profile
RG 7258
Alternative Names: RG7258Latest Information Update: 31 Jul 2012
Price :
$50
*
At a glance
- Originator Roche
- Class Antiasthmatics; Monoclonal antibodies
- Mechanism of Action Cytokine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 26 Jul 2012 Discontinued - Phase-I for Asthma in Switzerland (Parenteral)
- 01 Feb 2012 Phase-I clinical trials in Asthma in Switzerland (Parenteral)